Zongming Lin

481 total citations
19 papers, 396 citations indexed

About

Zongming Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Zongming Lin has authored 19 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Zongming Lin's work include Renal cell carcinoma treatment (11 papers), Epigenetics and DNA Methylation (7 papers) and Renal and related cancers (6 papers). Zongming Lin is often cited by papers focused on Renal cell carcinoma treatment (11 papers), Epigenetics and DNA Methylation (7 papers) and Renal and related cancers (6 papers). Zongming Lin collaborates with scholars based in China. Zongming Lin's co-authors include Jiejie Xu, Le Xu, Huimin An, Yu Zhu, Jianping Zhang, Li Liu, Tao Lv, Hao Yan, Yuan Chang and Rong Ding and has published in prestigious journals such as The Journal of Urology, European Journal of Cancer and Cell Death and Disease.

In The Last Decade

Zongming Lin

19 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zongming Lin China 12 226 134 132 99 53 19 396
HyoungBin Oh United States 6 271 1.2× 66 0.5× 195 1.5× 58 0.6× 19 0.4× 7 435
Ghada Kurban Canada 8 361 1.6× 80 0.6× 147 1.1× 233 2.4× 30 0.6× 9 518
Bastien Kaniewski France 10 235 1.0× 102 0.8× 47 0.4× 90 0.9× 66 1.2× 12 429
Irene Forno Italy 12 277 1.2× 151 1.1× 49 0.4× 136 1.4× 27 0.5× 15 541
Tracy L. Krebs United States 6 267 1.2× 110 0.8× 82 0.6× 58 0.6× 33 0.6× 10 364
Albin Rudisch Austria 6 178 0.8× 151 1.1× 42 0.3× 90 0.9× 54 1.0× 7 325
Guetchyn Millien United States 9 214 0.9× 160 1.2× 143 1.1× 49 0.5× 44 0.8× 10 421
Bill Wondergem United States 7 272 1.2× 69 0.5× 159 1.2× 137 1.4× 21 0.4× 7 393
Shigeki Kaneko Japan 8 327 1.4× 80 0.6× 220 1.7× 230 2.3× 9 0.2× 9 454

Countries citing papers authored by Zongming Lin

Since Specialization
Citations

This map shows the geographic impact of Zongming Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zongming Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zongming Lin more than expected).

Fields of papers citing papers by Zongming Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zongming Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zongming Lin. The network helps show where Zongming Lin may publish in the future.

Co-authorship network of co-authors of Zongming Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Zongming Lin. A scholar is included among the top collaborators of Zongming Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zongming Lin. Zongming Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhang, Jianping, Shengming Jin, Wenjun Xiao, et al.. (2021). Long noncoding RNA LINC00641 promotes renal cell carcinoma progression via sponging microRNA-340-5p. Cancer Cell International. 21(1). 210–210. 12 indexed citations
3.
Yan, Hao, et al.. (2021). Histone demethylase KDM4D inhibition suppresses renal cancer progression and angiogenesis through JAG1 signaling. Cell Death Discovery. 7(1). 284–284. 11 indexed citations
4.
Yan, Hao, et al.. (2021). High Expression of JMJD4 Is a Potential Diagnostic and Prognostic Marker of Renal Cell Carcinoma. Disease Markers. 2021. 1–19. 2 indexed citations
6.
Liu, Yidong, Le Xu, Lin Zhou, et al.. (2017). High truncated-O-glycan score predicts adverse clinical outcome in patients with localized clear-cell renal cell carcinoma after surgery. Oncotarget. 8(45). 80083–80092. 2 indexed citations
7.
Liu, Yidong, Le Xu, Yuan Chang, et al.. (2016). High mucin-7 expression is an independent predictor of adverse clinical outcomes in patients with clear-cell renal cell carcinoma. Tumor Biology. 37(11). 15193–15201. 10 indexed citations
8.
Zhou, Lin, Yuan Chang, Le Xu, et al.. (2016). The Presence of Vascular Mimicry Predicts High Risk of Clear Cell Renal Cell Carcinoma after Radical Nephrectomy. The Journal of Urology. 196(2). 335–342. 6 indexed citations
9.
Zhu, Yanhui, et al.. (2015). p21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma. Cell Death and Disease. 6(2). e1637–e1637. 43 indexed citations
10.
An, Huimin, Le Xu, Yuan Chang, et al.. (2015). CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma. European Journal of Cancer. 51(14). 1953–1961. 22 indexed citations
11.
Chang, Yuan, Qiang Fu, Le Xu, et al.. (2015). Prognostic value of preoperative lymphocyte to monocyte ratio in patients with nonmetastatic clear cell renal cell carcinoma. Tumor Biology. 37(4). 4613–4620. 18 indexed citations
12.
Chang, Yuan, Le Xu, Huimin An, et al.. (2015). Expression of IL-4 and IL-13 predicts recurrence and survival in localized clear-cell renal cell carcinoma.. PubMed. 8(2). 1594–603. 18 indexed citations
13.
Liu, Yujun, Yu Zhu, Haixia Yuan, et al.. (2014). Overexpression of HOXC11 homeobox gene in clear cell renal cell carcinoma induces cellular proliferation and is associated with poor prognosis. Tumor Biology. 36(4). 2821–2829. 24 indexed citations
14.
Xu, Le, Huimin An, Yidong Liu, et al.. (2014). Clinical significance of tumor-derived IL-1β and IL-18 in localized renal cell carcinoma: Associations with recurrence and survival. Urologic Oncology Seminars and Original Investigations. 33(2). 68.e9–68.e16. 36 indexed citations
15.
Zhu, Yu, Le Xu, Jianping Zhang, et al.. (2013). Sunitinib induces cellular senescence via p53/Dec1 activation in renal cell carcinoma cells. Cancer Science. 104(8). 1052–1061. 63 indexed citations
16.
Zhu, Yu, Le Xu, Jianping Zhang, et al.. (2013). Klotho suppresses tumor progression via inhibiting PI3K/Akt/GSK3β/Snail signaling in renal cell carcinoma. Cancer Science. 104(6). 663–671. 68 indexed citations
17.
Xu, Le, Yu Zhu, Jiejie Xu, et al.. (2012). Notch1 activation promotes renal cell carcinoma growth via PI3K/Akt signaling. Cancer Science. 103(7). 1253–1258. 24 indexed citations
18.
Hu, Xiaoyi, et al.. (2010). Preliminary clinical study results of sunitinib in patients with metastatic renal cell carcinoma. Zhonghua miniao waike zazhi. 31(5). 300–303. 1 indexed citations
19.
Huang, Chun‐Che, et al.. (2000). [Multivariate analysis of prognostic factors in renal cell carcinoma].. PubMed. 38(6). 442–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026